Sort
48,018 grants matching “immunotherapy”
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$948,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI
A Cytomegalovirus-based therapeutic vaccine against oncogenic human papillomaviruses
$948,184Eric Bruening · Tomegavax, Inc. · R44 · FY2016 · CA
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$948,099Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2023 · CA
Immunotherapy for Malignant Mesothelioma
$947,902Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Comparative Modeling for the Prevention and Control of Uterine Cancer
$947,887Jason Wright · Columbia University Health Sciences · U01 · FY2021 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$947,589Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA
DEVELOPMENTAL FUNDS (Core 002)
$947,406Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA
Neonatal Porcine Islet Xenografts for the Treatment of Type 1 Diabetes
$947,320Allan D. Kirk · Duke University · U01 · FY2016 · AI
Administrative Core
$947,067Jun Yan · University Of Louisville · P20 · FY2024 · GM
Center for Cancer Immunology and Immunotherapy (CCII).
$947,067Jun Yan · University Of Louisville · P20 · FY2024 · GM
05 Tissue Biospecimen and Pathology Resource
$947,051Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2023 · CA
05 Tissue Biospecimen and Pathology Resource
$947,051Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2022 · CA
05 Tissue Biospecimen and Pathology Resource
$947,051Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2019 · CA
05 Tissue Biospecimen and Pathology Resource
$947,051Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2021 · CA
Targeting Blys/Baff in non-human primate islet transplantation
$947,016Ali Naji · University Of Pennsylvania · U01 · FY2016 · AI
SUSTAINED RELEASE, STIMULI RESPONSIVE, RELOADABLE, SMART HYDROGELS FOR GRAFT-TARGETED IMMUNOTHERAPY IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
$946,995Wake Forest University Health Sciences · · FY2015 · Department of the Army
Understanding and Addressing Cancer Health Disparities in Louisiana
$946,797Augusto C Ochoa · Lsu Health Sciences Center · P20 · FY2019 · CA
EPIGENOMIC PRIMING AS AN IMMUNOTHERAPY ENHANCER IN OVARIAN CANCER
$946,629Northwestern University · · FY2017 · Department of the Army
Mechanisms of impaired T-cell mechanosensing of melanoma antigens
$946,295Cheng Zhu · Georgia Institute Of Technology · U01 · FY2020 · CA
Overcoming resistance to anti-PD1 immunotherapy
$946,072Thomas F Gajewski · University Of Chicago · R35 · FY2020 · CA
Overcoming resistance to anti-PD1 immunotherapy
$946,072Thomas F Gajewski · University Of Chicago · R35 · FY2018 · CA
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
$945,993Vikas R. Dharnidharka · Rutgers Biomedical And Health Sciences · U01 · FY2025 · CA
Defining the Importance of Immunity to NY-ESO-1 in Melanoma Therapy and Prognosis
$945,556Jedd D. Wolchok · Sloan-Kettering Inst Can Research · RC2 · FY2010 · CA
05 Tissue Biospecimen and Pathology Resource
$945,434Ignacio I. Wistuba · University Of Tx Md Anderson Can Ctr · P30 · FY2020 · CA
Antibody Based Therapeuticcs for Chikungunya Virus
$944,844Michael S. Diamond · Washington University · R01 · FY2012 · AI